Biwako turns your innovations into demonstrated results.
Healthcare innovations rarely fail due to a lack of ideas.
They fail due to limited access to data, insufficient structuring, and inadequate regulatory control.
Biwako removes these barriers.
We operate projects that integrate:
- Secure access to health data
- Access to biological samples
- Design and conduct of data-driven research projects and interventional clinical studies
- Comprehensive regulatory management (Ethics Committees, ANSM, CNIL, MR-00x frameworks)
We provide strategic guidance, but above all, we structure, submit, coordinate and deliver.
Don’t hesitate, contact us
Who are you ?
Biwako’s
missions 
The BIWAKO company was created in 2022 by Professor Marie Brevet, a doctor specializing in Pathological Anatomy and Cytology, passionate about innovation and medical research.
It addresses a critical need to reduce the time between scientific innovation, clinical validation, and effective availability for patients and healthcare professionals.
Its mission is to accelerate, structure, and secure the transition from idea to evidence, and from evidence to clinical use.
They speak about Biwako
The rise of agentic AI in pathology • healthcare-in-europe.com